Cummings Keith Lamont
SEC CIK 1809204 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | CFO | 297.2K | — | $2.41M | 21 | 2021-09-03 | 2026-01-20 |
Most active insiders at PLRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coulie Bernard | Pres, CEO, Dir | — | $114.4K |
| 2 | Cummings Keith Lamont | CFO | — | $30.7K |
| 3 | Cheung Lily | Chief Human Resource Off | — | $9,644 |
| 4 | Kuo Minnie | COO | — | $8,854 |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $1.28 | -24.0K | 297.2K | -7% | -$30.7K | |
| D | 2025-01-27 | 2025-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +56.6K | 319.3K | +22% | $0 |
| 2025-01-22 | 2025-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $11.20 | -20.1K | 262.6K | -7% | -$225.7K | |
| 2024-07-12 | 2024-07-10 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $11.56 | -10.9K | 282.1K | -4% | -$126.1K | |
| 2024-07-11 | 2024-07-09 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +21.3K | 293.0K | +8% | $0 | |
| D | 2024-05-06 | 2024-05-02 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +21.0K | 271.7K | +8% | +$43.7K |
| D | 2024-01-24 | 2024-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +55.2K | 249.9K | +28% | $0 |
| 2024-01-19 | 2024-01-17 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $17.23 | -9,781 | 194.6K | -5% | -$168.5K | |
| 2023-07-19 | 2023-07-17 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $18.01 | -19.8K | 204.0K | -9% | -$356.1K | |
| 2023-07-18 | 2023-07-14 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +38.8K | 223.8K | +21% | $0 | |
| D | 2023-06-14 | 2023-06-13 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +30.8K | 185.0K | +20% | +$64.0K |
| D | 2023-06-12 | 2023-06-09 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +5,800 | 154.3K | +4% | +$12.1K |
| 2023-04-03 | 2023-03-30 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $26.52 | -9,960 | 148.5K | -6% | -$264.1K | |
| 2023-03-31 | 2023-03-29 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +19.4K | 158.4K | +14% | $0 | |
| D | 2023-01-27 | 2023-01-25 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +54.0K | 138.4K | +64% | $0 |
| DM | 2023-01-25 | 2023-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $4.50 | +30.0K | 96.9K | +45% | +$134.8K |
| D | 2023-01-25 | 2023-01-23 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale+OE | $35.00 | -30.0K | 84.4K | -26% | -$1.05M |
| D | 2022-12-27 | 2022-12-22 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +4,000 | 84.4K | +5% | +$8,320 |
| 2022-12-21 | 2022-12-19 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +19.4K | 90.1K | +27% | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | S - Sale | $19.10 | -9,643 | 80.4K | -11% | -$184.2K | |
| D | 2021-09-03 | 2021-09-03 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +20.0K | 67.6K | +42% | +$41.6K |
Purchase Sale Sale after option exercise All abbreviations